AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mills, S.J.
Right arrow Articles by Jackson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mills, S.J.
Right arrow Articles by Jackson, A.

Do Cerebral Blood Volume and Contrast Transfer Coefficient Predict Prognosis in Human Glioma?

S.J. Millsa, T.A. Patankara, H.A. Haroona, D. Balériauxc, R. Swindellb and A. Jacksona

a Department of Imaging Science and Biomedical Engineering, Christie Hospital NHS Trust, Manchester, United Kingdom
b University of Manchester, and the Department of Medical Statistics, Christie Hospital NHS Trust, Manchester, United Kingdom
c Service de Radiologie Hôpital Erasme, Cliniques Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium


Figure 1
View larger version (12K):

[in a new window]
 
Fig 1. A, Cerebral blood volume (CBV) versus patient survival for tumor grades II–IV (WHO classification).

B, Ktrans versus patient survival for tumor grades II–IV (WHO classification).


Figure 2
View larger version (10K):

[in a new window]
 
Fig 2. A, Boxplots showing median, interquartile range (box), and extreme values of cerebral blood volume (CBV) for tumor grades II–IV (WHO classification).

B, Boxplots showing median, interquartile range (box), and extreme values of Ktrans for tumor grades II–IV (WHO classification).


Figure 3
View larger version (10K):

[in a new window]
 
Fig 3. A, Kaplan Meier survival curve for histologic grade of tumor (according to WHO classification).

B, Kaplan Meier survival curve for arbitrary groups of cerebral blood volume (CBV), irrespective of grade (group 1 [n = 6]; range, 0.60%–1.60%; group 2 [n = 7]; range, 1.88%–2.54%; group 3 [n = 7]; range, 2.80%–3.53%; group 4 [n = 7]; range, 3.56%–6.31%).

C, Kaplan Meier survival curve for arbitrary groups of Ktrans, irrespective of grade (group 1 [n = 6]; range, 0.00017–0.00054 minutes–1; group 2 [n = 7]; range, 0.001–0.008 minutes–1; group 3 [n = 7]; range, 0.009–0.025 minutes–1; group 4 [n = 7]; range, 0.027–0.056 minutes–1).


Figure 4
View larger version (12K):

[in a new window]
 
Fig 4. Kaplan Meier survival curve for arbitrary groups of Ktrans in grade IV tumors only (group 1 [n = 5]; range, 0.0013–0.009 minutes–1; group 2 [n = 5]; range, 0.016–0.029 minutes–1; group 3 [n = 7]; range, 0.034–0.056 minutes–1).


Figure 5
View larger version (8K):

[in a new window]
 
Fig 5. Relationship of Ktrans with patient survival in high grade (III and IV) tumors. Linear regression shows increasing survival with increasing Ktrans (ß = 0.556; R2 = 0.309; P < .01).